α-synuclein seeding aggregation assays (αSyn-SAAs) were recently established that diagnose α-synucleinopathy in PD with high sensitivity and specificity, therefore enabling the identification of molecular heterogeneity and increased PD risk among patients. The gene discussed is PCSK1N; the disease is Parkinson disease.